Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension

Chinese Medical Journal

Volumn 126, Issue 4, 2013, Pages 646-649

  Fang, Chang ^a   Lei, Juan ^a   Zhou, Shu Xian ^a   Zhang, Yu Ling ^a   Yuan, Gui Yi ^a   Wang, Jing Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Endothelial function; Hypertension; Inflammatory factor; Resistin

Indexed keywords

ENDOTHELIN 1; GLUCOSE; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874177254     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20120970     Document Type: Article

References (21)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
2. Patel L, Buckels AC, Kinghom IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476.
3. Yang RZ, Huang Q, Xu A, McLenithan JC, Eisen JA, Shuldiner AR, et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 2003; 310: 927-935.
4. Kougia P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg 2005; 41: 691-698.
5. Hu WL, Qiao SB, Hou Q, Yuan JS. Plasma resistin is increased in patients with unstable angina. Chin Med J 2007; 120: 871-875.
6. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M, et al. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 2008; 51: 534-539.
7. Tan MS, Shang SY, Chang DM, Tsai JC, Lee YJ. Association of resistin gene 3-untranslated region +62GA polymorphism with type 2 diabetes and hypertension in a chinese population. J Clin Endocrinol Metab 2003; 88: 1258-1263.
8. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78: 539-552.
9. Liu LS, Writing group of 2010 Chinese guidelines for the management of hypertension. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol (chin) 2011; 39: 579-615.
10. Lee SH, Lee BW, Won HK, Moon JH, Kim KJ, Kang ES, et al. Postprandial triglyceride is associated with fasting triglyceride and HOMA-IR in Korean subjects with type 2 diabetes. Diabetes Metab J 2011; 35: 404-410.
11. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795.
12. Papadopoulos DP, Perrea D, Thomopoulos C, Sanidas E, Daskalaki M, Papazachou U, et al. Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels. J Clin Hypertens (Greenwich) 2009; 11: 61-65.
13. Silswa LN, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappa B dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101.
14. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further envidence of adipoline-endothelial interaction. Circulation 2003; 108: 736-740.
15. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004; 314: 415-419.
16. Dimitriadis K, Tsioufis C, Selima M, Tsiachris D, Miliou A, Kasiakogias A, et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens 2009; 23: 668-673.
17. Yang J, Li XL, Huang J, Tao F, Li J, Xu Q, et al. Relationship between serum resistin level and large arterial elasticity in patients with essential hypertension. Chin J Cardiol (Chin) 2009; 37: 244-247.
18. Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 2009; 17: 216-221.
19. Tsioufis C, Dimitriadis K, Selima M, Miliou A, Toutouzas K, Roussos D, et al. Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypertension. Am J Hypertens 2010; 23: 681-686.
20. Shin HJ, Park S, Yoon SJ, Choi DS, Cho DK, Kim JS, et al. Association between serum resistin and carotid intima media thickness in hypertension patients. Int J Cardiol 2008; 125: 79-84.
21. Van Dyke TE, Kornman KS. Inflammation and factors that may regulate inflammatory response. J Periodontol 2008; 79: 1503-1507.